Paresthesia-Free Dorsal Root Ganglion Stimulation: An ACCURATE Study Sub-Analysis
| Autor: | Eric Grigsby, Peter S. Staats, Timothy R. Deer, Allen W. Burton, William Porter McRoberts, Jeffery M. Kramer, Kasra Amirdelfan, Lawrence Poree, Nagy Mekhail, Richard Paicius, Adil Raza, Jason E. Pope, Alexander R. Kent, Abram H. Burgher, Samuel Samuel, Michael Schaufele, Stanley Golovac, James Scowcroft, Robert M. Levy, Leonardo Kapural |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male Pain relief Stimulation law.invention 03 medical and health sciences 0302 clinical medicine Dorsal root ganglion Quality of life Randomized controlled trial law Ganglia Spinal Sensation medicine Humans Paresthesia Aged Spinal Cord Stimulation business.industry Chronic pain General Medicine Middle Aged medicine.disease Implantable Neurostimulators Anesthesiology and Pain Medicine Complex regional pain syndrome medicine.anatomical_structure Neurology Anesthesia Female Neurology (clinical) Chronic Pain business 030217 neurology & neurosurgery Follow-Up Studies |
| Zdroj: | Neuromodulation: Technology at the Neural Interface. 23:185-195 |
| ISSN: | 1094-7159 |
| Popis: | Introduction ACCURATE, a randomized controlled trial comparing dorsal root ganglion (DRG) stimulation to spinal cord stimulation, showed that DRG stimulation is a safe and effective therapy in individuals with lower extremity chronic pain due to complex regional pain syndrome (CRPS) type I or II. Investigators noted that DRG stimulation programming could be adjusted to minimize, or eliminate, the feeling of paresthesia while maintaining adequate pain relief. The present study explores treatment outcomes for DRG subjects who were paresthesia-free vs. those who experienced the sensation of paresthesia, as well as the factors that predicted paresthesia-free analgesia. Methods A retrospective analysis of therapy outcomes was conducted for 61 subjects in the ACCURATE study who received a permanent DRG neurostimulator. Outcomes of subjects who were paresthesia-free were compared to those who experienced paresthesia-present therapy at 1, 3, 6, 9, and 12-month follow-ups. Predictor variables for the presence or absence of paresthesias with DRG stimulation were also explored. Results The percentage of subjects with paresthesia-free pain relief increased from 16.4% at 1-month to 38.3% at 12-months. Paresthesia-free subjects generally had similar or better outcomes for pain severity, pain interference, quality of life, and mood state as subjects with paresthesia-present stimulation. Factors that increased the odds of a subject feeling paresthesia were higher stimulation amplitudes and frequencies, number of implanted leads, and younger age. Conclusions Some DRG subjects achieved effective paresthesia-free analgesia in the ACCURATE trial. This supports the observation that paresthesia is not synonymous with pain relief or required for optimal analgesia with DRG stimulation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect